Background: Prodromal dementia with Lewy bodies (DLB) can emerge with the onset of mild
cognitive impairment (MCI). Standard biomarkers can help identify such patients to improve …

Dementia with Lewy bodies (DLB) is an insidious neurodegenerative disease characterised
by a precipitous decline in cognition, sleep disturbances, motor impairment and psychiatric …

Dementia with Lewy bodies (DLB) is a prevalent neurodegenerative dementia (Walker et al.,
2015). In recent years, early diagnosis of DLB has attracted growing attention as three …

Background: Dementia must be diagnosed accurately and early in the disease course to
allow pathology-specific treatments to be effective. Dementia with Lewy bodies (DLB) is …

Background Isolated subjective cognitive impairment (SCI) and mild cognitive impairment
(MCI) are the prodromal phases of dementia with Lewy bodies (DLB). MEMENTO is a …

Objectives The aim of this review was to provide an overview of the literature on imaging in
prodromal dementia with Lewy bodies (DLB). Design Systematic PubMed search and …

Objective Early biomarkers for dementia with Lewy bodies (DLB) are lacking. To determine
whether EEG differentiates the prodromal phase of DLB from other causes of mild cognitive …

This pragmatic review synthesises the current understanding of prodromal dementia with
Lewy bodies (pDLB) and prodromal Alzheimer's disease (pAD), including clinical …

BackgroundThe clinical condition of dementia is now recognized as a diagnosis that can
only be applied too late in the disease process to be useful for therapeutic approaches …

Background Dementia with Lewy bodies (DLB) shares common clinical, neuropsychological
and pathological features with other dementia subtypes, such as Alzheimer's disease (AD) …